IBDEI1PS ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27388,1,4,0)
 ;;=4^T38.3X6A
 ;;^UTILITY(U,$J,358.3,27388,2)
 ;;=^5049649
 ;;^UTILITY(U,$J,358.3,27389,0)
 ;;=T38.3X6S^^110^1325^4
 ;;^UTILITY(U,$J,358.3,27389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27389,1,3,0)
 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sequela
 ;;^UTILITY(U,$J,358.3,27389,1,4,0)
 ;;=4^T38.3X6S
 ;;^UTILITY(U,$J,358.3,27389,2)
 ;;=^5049651
 ;;^UTILITY(U,$J,358.3,27390,0)
 ;;=T38.3X6D^^110^1325^5
 ;;^UTILITY(U,$J,358.3,27390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27390,1,3,0)
 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sub Encntr
 ;;^UTILITY(U,$J,358.3,27390,1,4,0)
 ;;=4^T38.3X6D
 ;;^UTILITY(U,$J,358.3,27390,2)
 ;;=^5049650
 ;;^UTILITY(U,$J,358.3,27391,0)
 ;;=T46.5X6A^^110^1325^9
 ;;^UTILITY(U,$J,358.3,27391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27391,1,3,0)
 ;;=3^Underdosing of Antihypertensive Drugs,Init Encntr
 ;;^UTILITY(U,$J,358.3,27391,1,4,0)
 ;;=4^T46.5X6A
 ;;^UTILITY(U,$J,358.3,27391,2)
 ;;=^5051353
 ;;^UTILITY(U,$J,358.3,27392,0)
 ;;=T46.5X6D^^110^1325^10
 ;;^UTILITY(U,$J,358.3,27392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27392,1,3,0)
 ;;=3^Underdosing of Antihypertensive Drugs,Subs Encntr
 ;;^UTILITY(U,$J,358.3,27392,1,4,0)
 ;;=4^T46.5X6D
 ;;^UTILITY(U,$J,358.3,27392,2)
 ;;=^5051354
 ;;^UTILITY(U,$J,358.3,27393,0)
 ;;=T46.5X6S^^110^1325^11
 ;;^UTILITY(U,$J,358.3,27393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27393,1,3,0)
 ;;=3^Underdosing of Antihypertensive Drugs,Sequela
 ;;^UTILITY(U,$J,358.3,27393,1,4,0)
 ;;=4^T46.5X6S
 ;;^UTILITY(U,$J,358.3,27393,2)
 ;;=^5051355
 ;;^UTILITY(U,$J,358.3,27394,0)
 ;;=T43.206A^^110^1325^6
 ;;^UTILITY(U,$J,358.3,27394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27394,1,3,0)
 ;;=3^Underdosing of Antidepressants,Init Encntr
 ;;^UTILITY(U,$J,358.3,27394,1,4,0)
 ;;=4^T43.206A
 ;;^UTILITY(U,$J,358.3,27394,2)
 ;;=^5050543
 ;;^UTILITY(U,$J,358.3,27395,0)
 ;;=T43.206S^^110^1325^7
 ;;^UTILITY(U,$J,358.3,27395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27395,1,3,0)
 ;;=3^Underdosing of Antidepressants,Sequela
 ;;^UTILITY(U,$J,358.3,27395,1,4,0)
 ;;=4^T43.206S
 ;;^UTILITY(U,$J,358.3,27395,2)
 ;;=^5050545
 ;;^UTILITY(U,$J,358.3,27396,0)
 ;;=T43.206D^^110^1325^8
 ;;^UTILITY(U,$J,358.3,27396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27396,1,3,0)
 ;;=3^Underdosing of Antidepressants,Subs Encntr
 ;;^UTILITY(U,$J,358.3,27396,1,4,0)
 ;;=4^T43.206D
 ;;^UTILITY(U,$J,358.3,27396,2)
 ;;=^5050544
 ;;^UTILITY(U,$J,358.3,27397,0)
 ;;=T43.506A^^110^1325^12
 ;;^UTILITY(U,$J,358.3,27397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27397,1,3,0)
 ;;=3^Underdosing of Antipsychotics & Neuroleptics,Init Encntr
 ;;^UTILITY(U,$J,358.3,27397,1,4,0)
 ;;=4^T43.506A
 ;;^UTILITY(U,$J,358.3,27397,2)
 ;;=^5050651
 ;;^UTILITY(U,$J,358.3,27398,0)
 ;;=T43.506S^^110^1325^13
 ;;^UTILITY(U,$J,358.3,27398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27398,1,3,0)
 ;;=3^Underdosing of Antipsychotics & Neuroleptics,Sequela
 ;;^UTILITY(U,$J,358.3,27398,1,4,0)
 ;;=4^T43.506S
 ;;^UTILITY(U,$J,358.3,27398,2)
 ;;=^5050653
 ;;^UTILITY(U,$J,358.3,27399,0)
 ;;=T43.506D^^110^1325^14
 ;;^UTILITY(U,$J,358.3,27399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27399,1,3,0)
 ;;=3^Underdosing of Antipsychotics & Neuroleptics,Subs Encntr
 ;;^UTILITY(U,$J,358.3,27399,1,4,0)
 ;;=4^T43.506D
 ;;^UTILITY(U,$J,358.3,27399,2)
 ;;=^5050652
 ;;^UTILITY(U,$J,358.3,27400,0)
 ;;=99211^^111^1326^1
 
--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1PS   3789     printed  Sep 23, 2025@19:49:26                                                                                                                                                                                                    Page 2
IBDEI1PS  ; ; 04-FEB-2020
 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 +2        if 'DIFQR(358.3)
               QUIT 
           FOR I=1:2
               SET X=$TEXT(Q+I)
               if X=""
                   QUIT 
               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
               SET X=$EXTRACT(X,4,999)
               if $ASCII(Y)=126
                   SET I=I+1
                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
               if $ASCII(Y)=61
                   SET Y=$EXTRACT(Y,2,999)
               XECUTE NO
              IF '$TEST
                   SET @X=Y
Q          QUIT 
 +1       ;;^UTILITY(U,$J,358.3,27388,1,4,0)
 +2       ;;=4^T38.3X6A
 +3       ;;^UTILITY(U,$J,358.3,27388,2)
 +4       ;;=^5049649
 +5       ;;^UTILITY(U,$J,358.3,27389,0)
 +6       ;;=T38.3X6S^^110^1325^4
 +7       ;;^UTILITY(U,$J,358.3,27389,1,0)
 +8       ;;=^358.31IA^4^2
 +9       ;;^UTILITY(U,$J,358.3,27389,1,3,0)
 +10      ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sequela
 +11      ;;^UTILITY(U,$J,358.3,27389,1,4,0)
 +12      ;;=4^T38.3X6S
 +13      ;;^UTILITY(U,$J,358.3,27389,2)
 +14      ;;=^5049651
 +15      ;;^UTILITY(U,$J,358.3,27390,0)
 +16      ;;=T38.3X6D^^110^1325^5
 +17      ;;^UTILITY(U,$J,358.3,27390,1,0)
 +18      ;;=^358.31IA^4^2
 +19      ;;^UTILITY(U,$J,358.3,27390,1,3,0)
 +20      ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sub Encntr
 +21      ;;^UTILITY(U,$J,358.3,27390,1,4,0)
 +22      ;;=4^T38.3X6D
 +23      ;;^UTILITY(U,$J,358.3,27390,2)
 +24      ;;=^5049650
 +25      ;;^UTILITY(U,$J,358.3,27391,0)
 +26      ;;=T46.5X6A^^110^1325^9
 +27      ;;^UTILITY(U,$J,358.3,27391,1,0)
 +28      ;;=^358.31IA^4^2
 +29      ;;^UTILITY(U,$J,358.3,27391,1,3,0)
 +30      ;;=3^Underdosing of Antihypertensive Drugs,Init Encntr
 +31      ;;^UTILITY(U,$J,358.3,27391,1,4,0)
 +32      ;;=4^T46.5X6A
 +33      ;;^UTILITY(U,$J,358.3,27391,2)
 +34      ;;=^5051353
 +35      ;;^UTILITY(U,$J,358.3,27392,0)
 +36      ;;=T46.5X6D^^110^1325^10
 +37      ;;^UTILITY(U,$J,358.3,27392,1,0)
 +38      ;;=^358.31IA^4^2
 +39      ;;^UTILITY(U,$J,358.3,27392,1,3,0)
 +40      ;;=3^Underdosing of Antihypertensive Drugs,Subs Encntr
 +41      ;;^UTILITY(U,$J,358.3,27392,1,4,0)
 +42      ;;=4^T46.5X6D
 +43      ;;^UTILITY(U,$J,358.3,27392,2)
 +44      ;;=^5051354
 +45      ;;^UTILITY(U,$J,358.3,27393,0)
 +46      ;;=T46.5X6S^^110^1325^11
 +47      ;;^UTILITY(U,$J,358.3,27393,1,0)
 +48      ;;=^358.31IA^4^2
 +49      ;;^UTILITY(U,$J,358.3,27393,1,3,0)
 +50      ;;=3^Underdosing of Antihypertensive Drugs,Sequela
 +51      ;;^UTILITY(U,$J,358.3,27393,1,4,0)
 +52      ;;=4^T46.5X6S
 +53      ;;^UTILITY(U,$J,358.3,27393,2)
 +54      ;;=^5051355
 +55      ;;^UTILITY(U,$J,358.3,27394,0)
 +56      ;;=T43.206A^^110^1325^6
 +57      ;;^UTILITY(U,$J,358.3,27394,1,0)
 +58      ;;=^358.31IA^4^2
 +59      ;;^UTILITY(U,$J,358.3,27394,1,3,0)
 +60      ;;=3^Underdosing of Antidepressants,Init Encntr
 +61      ;;^UTILITY(U,$J,358.3,27394,1,4,0)
 +62      ;;=4^T43.206A
 +63      ;;^UTILITY(U,$J,358.3,27394,2)
 +64      ;;=^5050543
 +65      ;;^UTILITY(U,$J,358.3,27395,0)
 +66      ;;=T43.206S^^110^1325^7
 +67      ;;^UTILITY(U,$J,358.3,27395,1,0)
 +68      ;;=^358.31IA^4^2
 +69      ;;^UTILITY(U,$J,358.3,27395,1,3,0)
 +70      ;;=3^Underdosing of Antidepressants,Sequela
 +71      ;;^UTILITY(U,$J,358.3,27395,1,4,0)
 +72      ;;=4^T43.206S
 +73      ;;^UTILITY(U,$J,358.3,27395,2)
 +74      ;;=^5050545
 +75      ;;^UTILITY(U,$J,358.3,27396,0)
 +76      ;;=T43.206D^^110^1325^8
 +77      ;;^UTILITY(U,$J,358.3,27396,1,0)
 +78      ;;=^358.31IA^4^2
 +79      ;;^UTILITY(U,$J,358.3,27396,1,3,0)
 +80      ;;=3^Underdosing of Antidepressants,Subs Encntr
 +81      ;;^UTILITY(U,$J,358.3,27396,1,4,0)
 +82      ;;=4^T43.206D
 +83      ;;^UTILITY(U,$J,358.3,27396,2)
 +84      ;;=^5050544
 +85      ;;^UTILITY(U,$J,358.3,27397,0)
 +86      ;;=T43.506A^^110^1325^12
 +87      ;;^UTILITY(U,$J,358.3,27397,1,0)
 +88      ;;=^358.31IA^4^2
 +89      ;;^UTILITY(U,$J,358.3,27397,1,3,0)
 +90      ;;=3^Underdosing of Antipsychotics & Neuroleptics,Init Encntr
 +91      ;;^UTILITY(U,$J,358.3,27397,1,4,0)
 +92      ;;=4^T43.506A
 +93      ;;^UTILITY(U,$J,358.3,27397,2)
 +94      ;;=^5050651
 +95      ;;^UTILITY(U,$J,358.3,27398,0)
 +96      ;;=T43.506S^^110^1325^13
 +97      ;;^UTILITY(U,$J,358.3,27398,1,0)
 +98      ;;=^358.31IA^4^2
 +99      ;;^UTILITY(U,$J,358.3,27398,1,3,0)
 +100     ;;=3^Underdosing of Antipsychotics & Neuroleptics,Sequela
 +101     ;;^UTILITY(U,$J,358.3,27398,1,4,0)
 +102     ;;=4^T43.506S
 +103     ;;^UTILITY(U,$J,358.3,27398,2)
 +104     ;;=^5050653
 +105     ;;^UTILITY(U,$J,358.3,27399,0)
 +106     ;;=T43.506D^^110^1325^14
 +107     ;;^UTILITY(U,$J,358.3,27399,1,0)
 +108     ;;=^358.31IA^4^2
 +109     ;;^UTILITY(U,$J,358.3,27399,1,3,0)
 +110     ;;=3^Underdosing of Antipsychotics & Neuroleptics,Subs Encntr
 +111     ;;^UTILITY(U,$J,358.3,27399,1,4,0)
 +112     ;;=4^T43.506D
 +113     ;;^UTILITY(U,$J,358.3,27399,2)
 +114     ;;=^5050652
 +115     ;;^UTILITY(U,$J,358.3,27400,0)
 +116     ;;=99211^^111^1326^1